Although 2-dimensional strain analyses based on speckle tracking echocardiography have been used to detect myocardial deformation, the prognostic impact of 2-dimensional strain is unclear in patients with acute decompensated heart failure (HF). We investigated whether left ventricular and right ventricular (RV) strain parameters assessed by speckle tracking echocardiography provide incremental prognostic information in hospitalized patients because of acute decompensated HF.
H
eart failure (HF) is a current epidemic of cardiovascular disease. Although there are several evidence-based medical therapies, patients with HF experience repeated hospitalization and have poor prognosis. 1 Therefore, it is critical to identify vulnerable HF patients at high risk of adverse outcome among patients hospitalized because of acute decompensated HF (ADHF). As echocardiography is the most feasible method for assessing cardiac morphologies and functions, many studies have evaluated the prognostic importance of echocardiographic parameters in HF patients. 2 Two-dimensional strain analyses based on speckle tracking echocardiography (STE) have recently been used to detect myocardial deformation. 3 Left ventricular global longitudinal strain (LV-GLS) and LV global circumferential strain (LV-GCS) are important prognostic indicators in patients with chronic HF. 4, 5 However, few studies have been conducted on the ADHF population. In addition, previous studies were limited to specific cohorts patients with HF with reduced ejection fraction (HFrEF) or those with HF with preserved EF (HFpEF) and did not fully adjust for laboratory findings, including hemoglobin, renal function, and brain natriuretic peptide (BNP), which are important risk factors for HF. 4, 5 Meanwhile, the importance of right ventricular (RV) systolic dysfunction is an independent predictor of adverse outcomes in patients with left-sided HF.
6 RVLS is also reported to predict adverse outcomes in HF, although such studies were small single-center studies limited to patients with HFrEF. 7 We hypothesized that compared with traditional echocardiographic measurements, LV and RV strain using 2-dimensional STE analysis may be more predictable parameters of adverse outcomes in patients with ADHF. Therefore, the aim of this prospective study was to investigate whether LV and RV strain parameters provide incremental prognostic information to clinical and echocardiographic findings in patients hospitalized because of ADHF.
METHODS

Study Design
The authors declare that all supporting data are available within the article. The present study was designed as the main study of the Ibaraki Cardiovascular Assessment Study for Heart Failure (ICAS-HF). Patients were enrolled from 11 cardiovascular centers between June 29, 2012 and March 30, 2015; clinical follow-up was completed by March 2016. This study was approved by the local ethics committee of each participating institution. All patients provided written informed consent before participation.
Patient Population and Evaluation
We included hospitalized patients of age >20 years with a clinical diagnosis of ADHF defined by the Framingham criteria at admission. 8 Patients who died during hospitalization, as well as those who had significant valvular heart disease or acute coronary syndrome were excluded. Significant valvular heart disease was defined as severe aortic or mitral stenosis and severe aortic or mitral regurgitation (MR) according to the latest American Heart Association/American College Cardiology guidelines. 9 With respect to severe MR, we excluded only primary MR which is caused by abnormality at any level of the mitral valve apparatus. After optimizing recommended medical treatment for HF, patients underwent physical examination, transthoracic echocardiography, and laboratory examination just before discharge. At the timing of echocardiographic assessment, patients were treated with only oral medication therapy with resolution of their symptoms.
CLINICAL PERSPECTIVE
Myocardial strain analyses based on speckle tracking echocardiography have been used to detect myocardial deformation. However, the prognostic impact of myocardial strain is unclear in patients with acute decompensated heart failure (ADHF). In this study, we investigated whether left ventricular and right ventricular (RV) strain parameters provide incremental prognostic information after discharge to clinical and echocardiographic findings in patients hospitalized because of ADHF. Among 618 consecutive patients hospitalized because of ADHF, 215 patients reached the end points defined as the composite of cardiovascular death and rehospitalization for HF during a median follow-up of 427 days. Impaired RV free wall strain (RV-fwLS ≥−13.1%) was an independent predictor of the composite end point after adjusting for clinical and other echocardiographic variables (adjusted hazard ratio, 1.51; 95% CI, 1.12-2.04; P=0.01). Moreover, we found that RV-fwLS was a significant predictor of poor prognosis in patients with HF with preserve ejection fraction as well as HF with reduced ejection fraction. In addition, RV-fwLS addition to baseline clinical information (age, New York Heart Association class III/IV, blood urea nitrogen level, and brain natriuretic peptide level) improved the risk classifications (integrated discrimination improvement 0.30, P=0.01; continuous net reclassification improvement 0.04,
P=0.01).
Among left ventricular and RV strain parameters, only RV-fwLS has an incremental value to identify the ADHF patients at high risk after discharge. Therefore, ADHF patients with impaired RV-fwLS at discharge should require close outpatient follow-up and more aggressive medical treatment to avoid cardiovascular events.
Echocardiography
We obtained measurements and recordings of each echocardiographic parameter according to the American Society of echocardiography guidelines. 10 Echocardiographic parameters were analyzed using workstations with vendor software packages: GE Healthcare (Milwaukee, WI), Philips (Andover), or Toshiba Medical Systems (Tochigi, Japan). All researchers at each institution were blinded to clinical information. LV enddiastolic interventricular septal thickness and end-diastolic posterior wall thickness were measured on the LV M-mode image from the standard parasternal short-axis view. LV end-diastolic volume and end-systolic volume were calculated using the Simpson biplane methods of disks. LVEF was calculated and expressed as a percentage. With the patient in the supine position, the maximum diameter of the inferior vena cava (IVC) was measured in the subcostal view 1.0 to 2.0 cm from the junction with the right atrium. Maximum left atrial (LA) volume was measured by the biplane Simpson's method and indexed to body surface area (LA volume index [LAVI]). Peak early (E) and late diastolic (A) velocities of the LV inflow, deceleration time of the E velocity, and the average of peak early diastolic velocity on the septal and the lateral corner of mitral annulus (e′) were measured in the apical 4-chamber view. The E/e′ ratio was obtained by dividing E by e′. Tricuspid regurgitation pressure gradient was derived from peak tricuspid regurgitation jet velocity. Tricuspid annular plane systolic excursion (TAPSE) was measured at RV free wall sight. Fractional area change was calculated by tracking the RV end-diastolic area (RVDA) and end-systolic area (RVSA) in the apical 4-chamber view using the following formula: {(RVDA−RVSA)/RVDA}×100. The severity of MR was graded semiquantitatively on the basis of the jet area of color-flow Doppler data. MR was characterized mild, moderate, or severe of jet area/LA area was <20%, 20% to 40%, and >40%, respectively.
Speckle Tracking Echocardiography
STE analyses were performed by dedicated analysts who were blinded to clinical information at the core laboratory, the University of Tsukuba, using vendor-independent 2D Cardiac Performance Analysis software (TomTec Imaging System, Munich, Germany). All study echocardiograms were sent in DICOM format to the core laboratory. For STE analysis, images were recorded at ≥50 frames per second to ensure reliable analysis by the software. At an end-systolic frame, a region of interest was traced on the endocardial cavity interface by using a point-and-click approach. The region of interest was automatically selected to approximate the myocardium between the endocardium and epicardium. The region of interest was adjusted further to ensure that all myocardial regions were included. Then, the software captured the myocardium, automatically tracking its motion and thickening on the subsequent frames. Finally, the myocardium was divided into 6 segments in each plane. For the assessment of RV strain, we evaluated the average value of the longitudinal peak systolic strain only from the free wall (RV-fwLS; Figure 1 ) and from all segments of the free wall and septal wall of the RV (RV-GLS) in the apical 4-chamber view focused in the RV. For the assessment of LV-GLS, the average of the longitudinal systolic negative peak values obtained from the 18 LV segments in the apical 4-, 3-, and 2-chamber views was calculated. To assess LV-GCS, we calculated the average of the circumferential systolic negative peak values in the middle myocardium using a 16-segment model obtained from the 3 short-axis planes at the basal, the papillary muscle, and apex levels. Segments were discarded if tracking was of poor quality.
Follow-Up and End Points
The attending physicians of each patient had to fill out clinical and echocardiographic findings on the ICAS Web database on registration. After discharge, patients were followed 3-month interval with the clinical visit. The attending physicians obtained follow-up information from reviewing patient's hospital charts, direct patients interview, letters from the referring physician, or contact with patient's family members, and updated the status of events on the ICAS Web database each time.
The primary end point was a composite of cardiovascular death or unplanned hospitalization because of worsening HF. In addition, cardiovascular death was assessed as the secondary end point. HF hospitalization was defined as an unplanned overnight stay in a hospital. The diagnosis of HF was defined according to Framingham criteria. 8 The patients should require treatment for especially HF, such as intravenous diuretics, intravenous vasodilators, intravenous inotropes, mechanical fluid removal (eg, ultrafiltration or dialysis), or insertion of an intra-aortic balloon pump for hemodynamic compromise. Cardiovascular death was defined HF death, fatal myocardial infarction, sudden death, stroke, cardiovascular procedure, or cardiovascular hemorrhage. HF death was defined as death associated with unstable, progressive deterioration of pump function, despite active therapy. Sudden death was defined as death that occurs unexpectedly and not within 30 days of an acute myocardial infarction.
Statistical Analysis
Continuous variables are presented as mean±SD and were analyzed by Student t test. When continuous variables had a skewed distribution, they were shown as median and interquartile range and were analyzed by Mann-Whitney U test. Categorical variables are presented as number (%) and were analyzed by the χ 2 test. We analyzed the relationships between RVLS and continuous variables by Pearson correlation coefficients. Time-dependent receiver operating characteristic curves were used to determine the optimal cutoff for the primary composite end point based on the Youden index.
Event rates are plotted in Kaplan-Meier curves for the primary composite end point and cardiovascular death, and groups were compared using the log-rank test.
Univariate and multivariable Cox proportional hazards models were performed to identify the independent determinants of the primary composite end point and cardiovascular death. Variables with P<0.05 at univariate analysis were included as covariables in multivariable models. Multivariable analyses were performed using a backward-conditional selection procedure on the remaining variables demonstrated a P value <0.05. Atrial fibrillation (AF), which has been shown to be important in several HF populations, 11 was forced into the multivariable models, because model's adjustments should take into account factors that are well known to be of clinical relevance. Moreover, LV-GLS, LV-GCS, RV-GLS, and RV-fwLS were introduced separately in the multivariable analysis to compare incremental value in predicting outcome.
To assess the incremental value of RV-fwLS in addition to conventional risk factors for predicting adverse events, we calculated the improvement in global χ 2 values. Reclassification of patients was calculated using the category-free versions of the net reclassification index and integrated discrimination improvement, as described by Pencina et al. 12 Subanalysis restricted to the patients with HFrEF if LVEF was <40% and those with HFpEF if LVEF was >50% according to the 2016 European HF guidelines were performed.
13 P values <0.05 were considered statistically significant. Statistical analyses were performed using JMP version 11.0.0 (SAS Institute Inc, Cary, NC) and R software (Version 3.4.4; Package survival-ROC and survIDINRI; R foundation for Statistical Computing, Vienna, Austria).
RESULTS
Baseline Characteristics
Patient flow diagram is presented in Figure 2 . Six hundred ninety-two patients met all inclusion and exclusion criteria. Seventy-four patients excluded from the study because of incomplete echocardiographic data or inadequate images for analyses. The final study population comprised 618 consecutive patients.
During a median follow-up of 427 (25th-75th percentile, 203-706) days, 215 primary end points occurred, including 81 cardiovascular deaths (61 were attributed to HF, 16 to out of hospital sudden death, 3 to rupture of aortic aneurysm, and 1 to stroke) and 134 rehospitalization with HF. Compared with patients without events, patients with events were significantly older and had a higher prevalence of New York Heart Association (NYHA) class III/IV, lower body mass index, lower diastolic blood pressure, higher blood urea nitrogen (BUN), higher BNP, lower hemoglobin, lower sodium, and lower estimated glomerular filtration rate (Table 1) . About oral medications, more patients with events received loop diuretics and amiodarone than those without events, whereas fewer patients with events received spironolactone than those without events. The echocardiography characteristics of the 2 groups are summarized in Table 2 . Patients with events had impaired RV-fwLS and RV-GLS in addition to larger LAVI, E/e′, tricuspid regurgitation pressure gradient, and IVC diameter, lower TAPSE, and a higher prevalence of severe secondary MR. In contrast, no statistically significant differences were observed in LVEF, LV-GLS, LV-GCS, and fractional area change between groups.
Relationships of RVLS With Clinical and Cardiac Factors
RV-fwLS was modestly correlated with LV-GLS (r=0.41; P<0.001) and LV-GCS (r=0.38; P<0.001), although RV-GLS was moderately correlated with both LV-GLS (r=0.52; P<0.001) and LV-GCS (r=0.47; P<0.001; Tables  I and II Supplement). About chronic obstructive pulmonary disease, RV-fwLS was not statistically different between groups with respect to the presence or absence of chronic obstructive pulmonary disease (−15.4±6.7%, −14.8±5.9%; P=0.54, respectively). In contrast, with respect to AF, RV-fwLS was significantly impaired in patients with AF compared with those without AF (−13.3±5.3%, −15.2±6.0%; P<0.001, respectively; Table III in the Data Supplement).
Predictors of Cardiac Events
The time-dependent receiver operating characteristic analysis determined the optimal RV-fwLS cutoff was −13.1% for predicting the primary composite end point. The other cutoff values were −9.8% for LV-GLS, −6.3% for LV-GCS, and −10.7% for RV-GLS, respectively. Of 267 patients with impaired RV-fwLS, 117 patients (≥−13.1%) reached the primary composite end point when compared with 98 of 351 patients with preserved RV-fwLS (<−13.1%; hazard ratio [HR], 1.70; 95% CI, 1.30-2.23; P<0.001; Figure 3A ; Table 3 ). Event-free survival was worse in patients with impaired RV-fwLS (≥−13.1%) than those with preserved RV-fwLS (<−13.1%) in both the HFpEF and HFrEF groups (Figure 3B and 3C) .
The RV-fwLS using cutoff value of −13.1% performed equally well as a prognostic indicator in the 586 patients without chronic obstructive pulmonary disease (HR, 1.72; 95% CI, 1.31-2.28; P<0.001)
In univariate analysis (Table 3) , TAPSE and RV-fwLS predicted the primary end point. In contrast, AF was not associated with cardiac events. After adjusting for conventional echocardiographic measures consider- Values are mean±SD or number (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; DCM, dilated cardiomyopathy; eGFR, estimated glomerular filtration rate; ICM, ischemic cardiomyopathy; NYHA, New York Heart Association; and SBP, systolic blood pressure. ing IVC diameter and the presence of severe secondary MR (model 1), RV-fwLS ≥−13.1%, the presence of severe secondary MR, and IVC diameter were significantly associated with cardiac events. After adjusting for diastolic blood pressure, AF, NYHA class III/ IV, BUN, and BNP in addition to model 1 (model 2; Table 4 ), impaired RV-fwLS ≥−13.1% was associated with a 1.5 higher risk of cardiac events, whereas the presence of severe secondary MR and IVC diameter were not significant predictors of cardiac events. In In the subanalysis restricted to the HFpEF group (n=206), impaired RV-fwLS (≥−13.1%) was also significantly associated with cardiac events in both the unadjusted and adjusted analyses (Table 5 ). Furthermore, in the subanalysis restricted to the HFrEF group (n=238), impaired RV-fwLS (≥−13.1%) and greater LAVI were significantly associated with cardiac events in unadjusted and adjusted analysis (Table 6 ).
Incremental Value of RV-fwLS for Predicting Adverse Events
Global χ 2 scores showed that RV-fwLS ≥−13.1% addition to models, including clinical data alone, had significant incremental value for both predicting the primary composite and cardiovascular death Cox proportional hazard model. BNP indicates brain natriuretic peptide; BUN, blood urea nitrogen; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FAC, fractional area change; HF, heart failure; HR, hazard ratio; IVC, inferior vena cava; LAVI, left atrial volume index; LV-GCS, left ventricular global circumferential strain; LV-GLS, left ventricular global longitudinal strain; MR, mitral regurgitation; NYHA, New York Heart Association; RV-fwLS, right ventricular free wall longitudinal strain; RV-GLS, right ventricular global longitudinal strain; and TAPSE, tricuspid annular plane systolic excursion.
(P<0.001; P=0.04, respectively). Addition of RV-fwLS ≥−13.1% to age, NYHA class III/IV, BUN, and BNP improved risk stratification for the primary composite end point (net reclassification index, 0.30; 95% CI, 0.07-0.49; P=0.01; integrated discrimination improvement, 0.04; 95% CI, 0.005-0.09; P=0.01), but not for 
Cox proportional hazard model. BNP indicates brain natriuretic peptide; BUN, blood urea nitrogen; DBP, diastolic blood pressure; HF, heart failure; HR, hazard ratio; IVC, inferior vena cava; LV-GCS, left ventricular global circumferential strain; LV-GLS, left ventricular global longitudinal strain; MR, mitral regurgitation; NYHA, New York Heart Association; RV-fwLS, right ventricular free wall longitudinal strain; and RV-GLS, right ventricular global longitudinal strain. Cox proportional hazards model. BNP indicates brain natriuretic peptide; BUN, blood urea nitrogen; DBP, diastolic blood pressure; E/ eʹ,ratio of early diastolic peak velocity of Doppler transmitral flow to early diastolic mitral annular velocity; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HR, hazard ratio; IVC, inferior vena cava; IVST, interventricular septal thickness; LAVI; left atrial volume index; LV-GCS, left ventricular global circumferential strain; LV-GLS, left ventricular global longitudinal strain; NYHA, New York Heart Association; and RV-fwLS, right ventricular free wall longitudinal strain. 
DISCUSSION
This study revealed that RV-fwLS is the most critical predictor of adverse outcomes in patients with ADHF even after adjusting for clinical variables and conventional echocardiographic parameters; it demonstrated incremental value in addition to age, NYHA class III/IV, BUN, and BNP. Meanwhile, left-sided parameters failed to provide prognostic information of adverse outcomes. Moreover, we found that RV-fwLS was a significant predictor of poor prognosis in patients with HFpEF, as well as HFrEF.
RV Function in ADHF Patients
Our results demonstrate that the ability of RV systolic function may directly affect cardiac events for patients with ADHF. Kjaergaard et al. 14 report that decreased TAPSE (<14 mm) was associated with increased mortality in 817 ADHF patients. However, to our knowledge, no study has investigated whether RVLS is associated with outcomes in patients with ADHF.
The failing LV secondarily aggravates RV dysfunction because of pulmonary venous hypertension. 15 Moreover, ventricular interdependence because of the interaction of the septum, limited pericardial flexibility, neurohormonal interactions, and myocardial ischemia of the RV because of decreased venous return are suggested to be the factors underlying RV dysfunction. 15 Our study demonstrated that AF was not associated with adverse outcome in patients with ADHF. Shotan et al. 11 reported that in patients with ADHF, permanent AF was associated with increased mortality, whereas intermittent AF was not. According to these results, whether AF is an independent factor in patients with HF primarily depends on the pattern of AF. However, we did not have data on the duration of AF.
In the present study, IVC diameter was associated with RV-fwLS and remained an independent predictor after adjusting for echocardiographic parameters (Table 3; Table I in the Data Supplement). IVC diameter was a surrogate marker of right atrial pressure. 16 Elevated right atrial pressure and central venous pressure are secondary to RV volume overload and exacerbate Cox proportional hazards model. BNP indicates brain natriuretic peptide; BUN, blood urea nitrogen; DBP, diastolic blood pressure; E/eʹ,ratio of early diastolic peak velocity of Doppler transmitral flow to early diastolic mitral annular velocity; eGFR, estimated glomerular filtration rate; HFrEF, heart failure with reduced ejection fraction; IVC, inferior vena cava; LAVI; left atrial volume index; LVEF, left ventricular ejection fraction; LV-GCS, left ventricular global circumferential strain; LV-GLS, left ventricular global longitudinal strain; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio, and RV-fwLS, right ventricular free wall longitudinal strain. systemic congestion and organ dysfunction, leading to poor prognosis. 17 
RV Strain in HFrEF Versus HFpEF
Iacoviello et al. 7 found that in 332 outpatients with chronic HF, RV-fwLS >−20.6% was associated with increased mortality in the absence of LV-GCS, LAVI, and IVC evaluation. In contrast to previous studies, we comprehensively evaluated both RV and LV function by 2-dimensional strain analyses. We found that besides not only RV-fwLS but also LAVI are independent predictors of cardiac events in HFrEF patients. LA size reflects the duration of exposure to increased LV-filling pressure, 18 therefore, LAVI might provide prognostic information in patients with HFrEF.
Whereas in the HFpEF group, only RV-fwLS was associated with cardiac events. Several recent reports suggest that RV dysfunction is associated with long-term outcome in patients with HFpEF. 5 There are 2 possible reasons for this. First, some patients with HFpEF may have out-ofproportion pulmonary hypertension, that is, the elevation of pulmonary artery pressure is greater than that expected from the elevation of LA pressure. The cause of this hemodynamic status is considered that precapillary vascular changes may develop earlier than expected. 19 Second, several noncardiac comorbidities in HFpEF, including hypertension, diabetes mellitus, chronic obstructive pulmonary disease, and obesity, are related to RV dysfunction. 20 In other words, RV dysfunction in HFpEF may be a surrogate marker of various comorbidities.
Prognostic Role of RV-fwLS and RV-GLS
Our study demonstrated that not RV-GLS but RV-fwLS was associated with cardiac events. The reason can be explained as follows. Our study showed that RV-GLS was more closely associated with LV systolic function than RV-fwLS (Table II in the Data Supplement). Our results showed neither LV-GLS nor LV-GCS was associated with cardiac events (Table 3) . Therefore, LV-GLS and LV-GCS may have a negative impact on RV-GLS to predict outcome. In addition, a recent experimental study showed that RV-fwLS contributed to RV stroke volume essentially. 21 These results collectively indicate that RV-fwLS is a more accurate marker of intrinsic RV systolic function and less reflective LV systolic function than RV-GLS.
Limitations
We included rehospitalization for HF as a composite end point although all participants had HF at baseline in the current study. It seems to be complicated, but we focused on secondary prevention of HF, because rehospitalization for HF caused to cardiac and renal injury, which can contribute to progression of HF.
1 CONCLUSIONS RV-fwLS assessed by STE provides additional information to predict clinical outcomes in patients with ADHF on the basis of LVEF and independent of HF type. This finding may be helpful for identifying vulnerable HF patients at high risk for cardiac events after discharge.
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